BAALC in neurogenesis and hematopoiesis

BAALC 在神经发生和造血中的作用

基本信息

  • 批准号:
    6826614
  • 负责人:
  • 金额:
    $ 30.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-22 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): According to the concept of hierarchical cell differentiation somatic stem cells gradually lose their potential to self renew and to produce more than one tissue type. Recently, this concept has been challenged by the demonstration that cells from adult organs may be converted into other tissue types. This phenomenon termed plasticity applies to subsets of cells known as tissue stem cells (TSC). The biology of these TSC is generally poorly understood in part due to the paucity of markers. The overall long-term goal of this proposal is to contribute to a better understanding of the cell differentiation process by determining the role of BAALC, a novel gene, in cell biology. BAALC is expressed in all neuroectodermal tissues including brain tumors, in CD34 positive bone marrow progenitors, and in leukemic blasts from a subset of patients with acute leukemia. In acute myeloid leukemia with normal karyotype, high expression of BAALC independently predicts poor prognosis, suggesting a role in malignancy. To understand the function of BAALC, and to determine whether it serves as a marker both for neurogenic and hematopoietic stem cells and affects their biology, animal modeling in mice will be pursued. Because the structure of BAALC gives no hints about its function, a conventional knockout mouse will be created that will show whether BAALC is vital for embryonic development. Moreover, by examining mice deficient in BAALC it will be determined what cells are mainly affected and at what developmental stage BAALC exerts its function. To specifically determine BAALC's role in neuropoiesis and hematopoiesis conditional, tissue-specific Baalc knockout mice will be generated using the Cre/IoxP recombination technology. These mice will provide insight into Baalc's role in neuropoiesis and hematopoiesis in vivo even in case the conventional knockout condition turns out to be lethal. The mice will be studied immunohistochemically, and by applying various cell lineage-, time-, and developmental stage-specific markers. It is postulated that the high degree of evolutionary conservation of BAALC in mammals will allow observations in mice to be applicable to humans.
描述(由申请人提供):根据分级细胞分化的概念,体干细胞逐渐失去其自我更新和产生一种以上组织类型的潜力。最近,这一概念受到了来自成人器官的细胞可以转化为其他组织类型的证据的挑战。这种被称为可塑性的现象适用于称为组织干细胞(TSC)的细胞亚群。这些TSC的生物学通常知之甚少,部分原因是缺乏标记物。该提案的总体长期目标是通过确定BAALC(一种新基因)在细胞生物学中的作用,有助于更好地理解细胞分化过程。BAALC在包括脑肿瘤在内的所有神经外胚层组织、CD 34阳性骨髓祖细胞和来自急性白血病患者亚组的白血病原始细胞中表达。在核型正常的急性髓系白血病中,BAALC的高表达独立地预测不良预后,提示在恶性肿瘤中的作用。为了了解BAALC的功能,并确定它是否作为神经源性干细胞和造血干细胞的标志物并影响其生物学,将在小鼠中建立动物模型。由于BAALC的结构没有给出关于其功能的提示,因此将创建一个常规敲除小鼠,以显示BAALC是否对胚胎发育至关重要。此外,通过检查BAALC缺陷的小鼠,将确定哪些细胞主要受到影响以及BAALC在哪个发育阶段发挥其功能。为了特异性地确定BAALC在神经生成和造血条件中的作用,将使用Cre/IoxP重组技术产生组织特异性Baalc敲除小鼠。这些小鼠将提供对Baalc在体内神经生成和造血中的作用的深入了解,即使在常规敲除条件被证明是致命的情况下。小鼠将进行化学研究,并通过应用各种细胞谱系,时间和发育阶段特异性标志物。据推测,BAALC在哺乳动物中的高度进化保守性将使小鼠中的观察结果适用于人类。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALBERT DE LA CHAPELLE其他文献

ALBERT DE LA CHAPELLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALBERT DE LA CHAPELLE', 18)}}的其他基金

Low-Penetrance Genes in the Predisposition to Papillary Thyroid Cancer
低外显率基因易患甲状腺乳头状癌
  • 批准号:
    8588543
  • 财政年份:
    2013
  • 资助金额:
    $ 30.65万
  • 项目类别:
Early Predisposing Genes and Risk Stratification for CLL
CLL 的早期易感基因和风险分层
  • 批准号:
    7715167
  • 财政年份:
    2009
  • 资助金额:
    $ 30.65万
  • 项目类别:
Genes in the Predisposition to Papillary Thyroid Carcinoma
甲状腺乳头状癌易感基因
  • 批准号:
    8505963
  • 财政年份:
    2008
  • 资助金额:
    $ 30.65万
  • 项目类别:
Genes in the Predisposition to Papillary Thyroid Carcinoma
甲状腺乳头状癌易感基因
  • 批准号:
    8697753
  • 财政年份:
    2008
  • 资助金额:
    $ 30.65万
  • 项目类别:
Genes in the Predisposition to Papillary Thyroid Carcinoma
甲状腺乳头状癌易感基因
  • 批准号:
    9246459
  • 财政年份:
    2008
  • 资助金额:
    $ 30.65万
  • 项目类别:
Microarray
微阵列
  • 批准号:
    7613101
  • 财政年份:
    2005
  • 资助金额:
    $ 30.65万
  • 项目类别:
Postdoctoral Training in Cancer Genetics
癌症遗传学博士后培训
  • 批准号:
    7487295
  • 财政年份:
    2004
  • 资助金额:
    $ 30.65万
  • 项目类别:
Postdoctoral Training in Cancer Genetics
癌症遗传学博士后培训
  • 批准号:
    8536086
  • 财政年份:
    2004
  • 资助金额:
    $ 30.65万
  • 项目类别:
Postdoctoral Training in Cancer Genetics
癌症遗传学博士后培训
  • 批准号:
    7905209
  • 财政年份:
    2004
  • 资助金额:
    $ 30.65万
  • 项目类别:
Postdoctoral Training in Cancer Genetics
癌症遗传学博士后培训
  • 批准号:
    7123033
  • 财政年份:
    2004
  • 资助金额:
    $ 30.65万
  • 项目类别:

相似海外基金

Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
  • 批准号:
    10655162
  • 财政年份:
    2023
  • 资助金额:
    $ 30.65万
  • 项目类别:
Rapid Acute Leukemia Genomic Profiling with CRISPR enrichment and Real-time long-read sequencing
利用 CRISPR 富集和实时长读长测序进行快速急性白血病基因组分析
  • 批准号:
    10839678
  • 财政年份:
    2023
  • 资助金额:
    $ 30.65万
  • 项目类别:
Rapid Acute Leukemia Genomic Profiling with CRISPR enrichment and Real-time long-read sequencing
利用 CRISPR 富集和实时长读长测序进行快速急性白血病基因组分析
  • 批准号:
    10651543
  • 财政年份:
    2023
  • 资助金额:
    $ 30.65万
  • 项目类别:
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
NUP98重排急性白血病的实验和临床前模型
  • 批准号:
    10829603
  • 财政年份:
    2023
  • 资助金额:
    $ 30.65万
  • 项目类别:
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia
预测儿童急性白血病甲氨蝶呤神经毒性的系统流行病学方法
  • 批准号:
    10655716
  • 财政年份:
    2023
  • 资助金额:
    $ 30.65万
  • 项目类别:
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
抗CD25放射免疫治疗和全骨髓照射治疗复发难治性急性白血病
  • 批准号:
    10435886
  • 财政年份:
    2022
  • 资助金额:
    $ 30.65万
  • 项目类别:
mRNA stability and its impact on hematopoiesis and acute leukemia
mRNA稳定性及其对造血和急性白血病的影响
  • 批准号:
    10339742
  • 财政年份:
    2022
  • 资助金额:
    $ 30.65万
  • 项目类别:
Diversifying Acute Leukemia Clinical Trial Enrollment Through Multilevel Intervention
通过多层次干预使急性白血病临床试验招募多样化
  • 批准号:
    10505579
  • 财政年份:
    2022
  • 资助金额:
    $ 30.65万
  • 项目类别:
Clonal dynamics and chemoresistance mechanisms of minimal residual disease in acute leukemia
急性白血病微小残留病的克隆动力学和化疗耐药机制
  • 批准号:
    10351765
  • 财政年份:
    2022
  • 资助金额:
    $ 30.65万
  • 项目类别:
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
抗CD25放射免疫治疗和全骨髓照射治疗复发难治性急性白血病
  • 批准号:
    10576955
  • 财政年份:
    2022
  • 资助金额:
    $ 30.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了